logo-loader
EnergyOil & Gas
Saudi Aramco

Saudi Arabia's Aramco set to snub London as Boris Johnson marches Britain towards ‘no-deal’ Brexit

London and Hong Kong had been tipped as early frontrunners in the race to land the Aramco IPO but it now appears Tokyo is the most likely destination for the equity float

Saudi Aramco - Saudi Arabia set to snub London as Boris Johnson marches toward ‘no-deal’ Brexit
The world's most profitable company won't be coming to London, according to reports

Brexit controversy and civil unrest are believed to be key factors in Saudi Aramco’s reported preference to take its initial public offer to Japan.

London and Hong Kong were seen as front-runners among the possible destinations for the world’s most profitable company as it seeks to partially float its equity on a globally recognised stock exchange.

Boris Johnson’s march towards 'no-deal' and Brexit's broader political and economic risks have evidently ruled out London.

Hong Kong’s civil unrest appears to have rendered it unattractive to Saudi officials who appear keen to promote a positive image through targeted promotional activity including international sporting events (such as Anthony Joshua’s upcoming ‘Clash on the Dunes’ boxing match) and high profile concerts.

A New York listing meanwhile appears less likely despite Donald Trump’s past attempts to appeal to Riyadh.

Media reports have suggested that despite its apparent strong ties to Trump, Aramco has been evaluating broader risks of listing in the United States, with the possibility for shareholder-linked protest around environmentalism cited as a concern.

With Tokyo presently seen as leading the race, it is anticipated that Aramco will shortly proceed with a phased floatation with an initial allocation of public shares in Riyadh later this year ahead of the international listing either next year or the year after.

Market commentators suggest Aramco will aim to sell some 5% of its equity for around US$100bn.

Responding to media reports, the Saudi Arabia oiler said that no final decision has yet been made.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: CB2 Insights licenses electronic data capture software to UK...

CB2 Insights (CSE:CBII-OTCQB: CBIIF) CEO Prad Sekar joined Steve Darling from Proactive Vancouver to discuss the company doing a deal with MYACCESS Clinics. This will allow CB2’s software to capture comprehensive data sets related to patient health and treatment histories and manage ongoing...

1 day, 11 hours ago

2 min read